MORGAN STANLEY - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,484
-83.2%
1,000
-85.7%
0.00%
Q2 2023$8,849
+119.9%
7,000
+133.3%
0.00%
Q1 2023$4,025
-14.7%
3,0000.0%0.00%
Q4 2022$4,721
-73.8%
3,000
-76.9%
0.00%
Q3 2022$18,000
+12.5%
13,000
+8.3%
0.00%
Q2 2022$16,0000.0%12,0000.0%0.00%
Q1 2022$16,000
+6.7%
12,0000.0%0.00%
Q4 2021$15,000
-25.0%
12,000
-20.0%
0.00%
Q3 2021$20,000
-99.8%
15,000
-99.8%
0.00%
-100.0%
Q2 2021$9,244,000
+37.1%
7,000,000
+40.0%
0.00%0.0%
Q1 2021$6,744,000
+45.3%
5,000,000
+48.5%
0.00%0.0%
Q4 2020$4,640,000
+42.2%
3,367,000
+42.2%
0.00%0.0%
Q3 2020$3,262,000
+42.4%
2,367,000
+71.9%
0.00%0.0%
Q2 2020$2,290,000
-69.8%
1,377,000
-76.8%
0.00%
-50.0%
Q1 2020$7,576,000
-20.2%
5,927,000
-4.7%
0.00%0.0%
Q4 2019$9,496,000
+17.7%
6,221,000
+5.7%
0.00%0.0%
Q3 2019$8,071,000
+82.5%
5,883,000
+75.6%
0.00%
+100.0%
Q2 2019$4,422,000
+43.4%
3,350,000
+46.9%
0.00%0.0%
Q1 2019$3,084,000
-21.8%
2,281,000
-30.9%
0.00%0.0%
Q4 2018$3,942,000
-52.2%
3,303,000
-31.4%
0.00%
-50.0%
Q3 2018$8,242,000
+336.3%
4,815,000
+269.5%
0.00%
+100.0%
Q2 2018$1,889,0001,303,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders